2025-05-02 09:59:26
Latest Post
Godrej Agrovet Limited consolidated Q4FY25 net profit drops QoQ to Rs. 70.78 crores
L G Balakrishnan & Bros Ltd posts Rs. 84.03 crores consolidated profit in Q4FY25
Swastika Investmart Ltd Q4 FY2025 consolidated profit slumps to Rs. 27.17 lakhs
Vertex Securities Ltd consolidated Q4 FY25 loss at Rs. 53.99 lakhs
The Federal Bank Limited consolidated Q4FY25 PAT jumps to Rs. 1108.31 crores
Stock Report
Shalby Ltd reports Rs. 16.82 crore consolidated PAT in Q3FY21
Posted On : 2021-01-10 17:35:57( TIMEZONE : IST )
Shalby Ltd has reported financial results for the period ended December 31, 2020.
Financial Results (Q3 FY20-21) - QoQ Comparison
The company has reported total income of Rs.134.05 crores during the period ended December 31, 2020 as compared to Rs.117.97 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.16.82 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.24.46 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.1.56 for the period ended December 31, 2020 as compared to Rs.2.27 for the period ended September 30, 2020.
| Financials | Q3 FY20-21 | Q2 FY20-21 | % Change |
| Total Income | ₹ 134.05 crs | ₹ 117.97 crs |  13.63% |
| Net Profit | ₹ 16.82 crs | ₹ 24.46 crs |  -31.23% |
| EPS | ₹ 1.56 | ₹ 2.27 | -31.28% |
Financial Results (Q3 FY20-21) - YoY Comparison
The company has reported total income of Rs.134.05 crores during the period ended December 31, 2020 as compared to Rs.123.13 crores during the period ended December 31, 2019.
The company has posted net profit / (loss) of Rs.16.82 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.8.14 crores for the period ended December 31, 2019.
The company has reported EPS of Rs.1.56 for the period ended December 31, 2020 as compared to Rs.0.75 for the period ended December 31, 2019.
| Financials | Q3 FY20-21 | Q3 FY19-20 | % Change |
| Total Income | ₹ 134.05 crs | ₹ 123.13 crs | 8.87% |
| Net Profit | ₹ 16.82 crs | ₹ 8.14 crs | 106.63% |
| EPS | ₹ 1.56 | ₹ 0.75 | 108% |
Financial Results (9 Months ended FY 20-21) - YoY Comparison
The company has reported total income of Rs.292.78 crores during the 9 months period ended December 31, 2020 as compared to Rs.385.22 crores during the 9 months period ended December 31, 2019.
The company has posted net profit / (loss) of Rs.32.58 crores for the 9 months period ended December 31, 2020 as against net profit / (loss) of Rs.44.69 crores for the 9 months period ended December 31, 2019.
The company has reported EPS of Rs.3.02 for the 9 months period ended December 31, 2020 as compared to Rs.4.14 for the 9 months period ended December 31, 2019.
| Financials | 9 Months ended FY20-21 | 9 Months ended FY19-20 | % Change |
| Total Income | ₹ 292.78 crs | ₹ 385.22 crs | -24% |
| Net Profit | ₹ 32.58 crs | ₹ 44.69 crs | -27.1% |
| EPS | ₹ 3.02 | ₹4.14 | -27.05% |
Commenting on performance, Mr. Shanay Shah, President said: "The company continues to respond to the pandemic and we are proud of the resiliency and perseverance demonstrated by the Shalby team during these challenging times. During the quarter, we treated over 2,700 Covid-19 patients across our hospital group and total surgeries performed were 1,840, a growth of 13.4% on q-o-q basis.
During the quarter, Shalby delivered robust performance that was in line with our expectations. Total income was at Rs. 1,317 million, an increase of 6.9% y-o-y and 17.8% on a q-o-q basis. This was driven by increased bed occupancy levels of 45% in Q3 FY21 as compared to 38% in the same quarter last year. The occupancy growth was underpinned by an increase in both the number of Covid-19 patients and elective surgeries.
EBITDA for the quarter was Rs. 323 million with margins of 24.5% as compared to 19.7% in Q3 FY20 and 28.0% in Q2 FY21. The y-o-y margin improvement was due to higher occupancy from Covid-19 patients resulting in lower usage of materials and consumables. Overall, net profit was Rs. 163 million with margins of 12.4%. Our balance sheet and cash flow generation remains strong with net cash of Rs. 598 million at the end of December 2020 compared with Rs. 398 million at the end of March 2020.
Looking ahead with a Covid-19 vaccine on the horizon, we are cautiously optimistic that a transition toward normalcy will soon begin although it will take time for the vaccine to have a pronounced effect on the pandemic. Management is fully committed to deliver uninterrupted healthcare services to its patients. We are confident that Shalby is well positioned for long-term success with its patient-focused approach and home care initiatives."
Shares of Shalby Ltd was last trading in BSE at Rs.121.35 as compared to the previous close of Rs. 130.8. The total number of shares traded during the day was 333838 in over 5131 trades.
The stock hit an intraday high of Rs. 134.8 and intraday low of 120.7. The net turnover during the day was Rs. 42894167.
